The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Impact of diabetes mellitus on inflammatory markers and severity scales in community-acquired pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Influence of comorbidities on pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020
Cavitary bacterial lung infections – Predictive factors and outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Microbial aetiology and outcomes of CAP in bronchiectatic patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Biomarkers and cardiovascular events in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014